Clinical Trial Update: Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Renalof for the dissolution of renal calculi in patients with recurrent calcic lithiasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Urolithiasis

Drugs mentioned

• Renalof

Snippet

Sponsor: Catalysis SL | Conditions: Recurrent Calcic Urolithiasis | Phase 3 | Status: COMPLETED